Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment.
about
Combined pharmacotherapy and behavioural interventions for smoking cessationAdditional behavioural support as an adjunct to pharmacotherapy for smoking cessationCombined pharmacotherapy and behavioural interventions for smoking cessationAntidepressants for smoking cessationBehavioural interventions as adjuncts to pharmacotherapy for smoking cessationPositive emotion and cardiovascular disease in elderly peopleCognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial PerspectivePharmacologic agents for tobacco dependence treatment: 2011 update.Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.Smiling Instead of Smoking: Development of a Positive Psychology Smoking Cessation Smartphone App for Non-daily Smokers.Anxiety and depressive symptoms and affective patterns of tobacco withdrawal.Reinforcing effects of smoking: more than a feeling.Don't worry, be happy: positive affect and reduced 10-year incident coronary heart disease: the Canadian Nova Scotia Health Survey.Associations of attention-deficit hyperactivity disorder symptom dimensions with smoking deprivation effects in adult smokers.Reward and affective regulation in depression-prone smokers.Positive reactions to tobacco predict relapse after cessation.Declining alternative reinforcers link depression to young adult smoking.Relationship between momentary affect states and self-efficacy in adolescent smokersCognitive deficits specific to depression-prone smokers during abstinence.Smoking-specific experiential avoidance cognition: explanatory relevance to pre- and post-cessation nicotine withdrawal, craving, and negative affectIncremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled studyMindfulness training for smoking cessation: results from a randomized controlled trial.Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers.Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach.Ecological evidence that affect and perceptions of drink effects depend on alcohol expectancies.Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatmentTobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinencePositive Psychotherapy for Smoking Cessation: A Pilot Randomized Controlled Trial.Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit.Racial/ethnic differences in the longitudinal progression of co-occurring negative affect and cigarette use: from adolescence to young adulthoodSmoking cue reactivity in adult smokers with and without depression: a pilot studyInfluence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion.Anhedonia, depressed mood, and smoking cessation outcome.Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms.Positive Psychotherapy for Smoking Cessation: Treatment Development, Feasibility and Preliminary ResultsAnxiety sensitivity and pre-cessation smoking processes: testing the independent and combined mediating effects of negative affect-reduction expectancies and motives.Smoking Cessation Treatment for Patients With Mental Disorders Using CBT and Combined Pharmacotherapy.Can repetitive mental simulation of smoking engender habituation?Tobacco Withdrawal Amongst African American, Hispanic, and White Smokers.
P2860
Q24186008-88D955AA-EF88-458F-9D15-7B13C9182E89Q24186545-256D9F4B-7425-463E-AADF-C83B3A4768ADQ24198116-632B1DB6-6945-4677-8E44-80565A7D9E99Q24201167-009E2F47-9F4F-4869-A35E-4538F34A0CA5Q24202466-1F1A8171-5790-4523-B10B-1FDED53F81F9Q26801931-24C42712-47A5-43E8-9C11-6994D7628377Q28071876-20DB98F5-0F10-4D83-B252-B32EF7D6AF79Q30408254-F38D4F99-F29F-4DB8-B9EA-AABB1E4EC4F7Q30655273-D4B3652F-013C-496A-81B6-51E5331A2890Q33452790-79BE16B9-2C26-4114-B634-10E53DA540EFQ33725094-0FFF3097-2BC5-4EB2-B6A9-2F2B338D3C8CQ33802985-68297B5C-DF86-4E1D-ADF8-21B7025DEF49Q33820847-3DF60BDA-0B34-4F6C-99F4-A76D0D6797D2Q34279982-C957BA2B-7EA5-48F7-BBF4-B3A378590FDFQ34294616-CB37F98B-228B-46C1-B0C8-4E4EABC06E39Q34331623-1454101E-D38F-4E01-B8D7-D61D1088A16BQ34424807-E537757F-1A44-46D6-850C-3A05140FB1D4Q34602493-6A3CBBB8-49C2-4B55-AEFA-C07D2253CA0CQ34762146-3EF02311-21BB-4013-BB0C-900E435C3226Q35058640-97AA5E8F-22CF-470C-BD99-02C27E866FE5Q35124169-0FC49616-5164-47D5-8826-7B42D011510EQ35317350-E7730847-BA93-4E28-99A9-80CA51AC9A71Q35545542-69426236-ADA7-4921-A6B5-0D4088ADFCA0Q35596398-2DCC740F-6C2D-465F-9241-E2801C81AFFFQ35907839-C0376FD0-828F-4614-AE88-EC8C6CB24112Q35911540-C4AA2D76-68BF-45C5-958E-5FBC5C653898Q36070186-14794212-C400-4F8A-8172-0FFFCCD5E413Q36181363-CBD09C77-CC5D-4DC6-BBE6-BFF500E67DBEQ36243678-14EE76B4-6DEE-472F-866A-E365C12EC7F5Q36421563-F856C026-47B6-49FC-8E40-2F7856A1FDE8Q36724320-A863C11D-B8EE-44D2-B0CE-9B9520F318C0Q36824940-B105C93E-BC16-4BE4-9745-40CFB99BE6E2Q37325773-179FF2AF-1466-4A7B-B697-1C594698109DQ37603411-7D7F327E-57B1-4E37-B0E4-84EEDAE5CDB2Q37603415-93D84A6C-355E-4ACE-9246-D64EDF03F873Q37661486-BEDE2F7A-FB8E-4C93-8C59-D0F79FD01F21Q37731421-20DF7E5A-E220-46B3-8F95-0F0B0AD45041Q38685629-887E901C-9720-4083-AF8E-8091482F59D9Q40435917-23C99A21-D62F-445E-92A2-431342D6A43AQ46078519-BE368D9B-A0A6-4F08-B00A-78DA700BB36F
P2860
Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of bupropion and cognit ...... ke during cessation treatment.
@en
Impact of bupropion and cognit ...... ke during cessation treatment.
@nl
type
label
Impact of bupropion and cognit ...... ke during cessation treatment.
@en
Impact of bupropion and cognit ...... ke during cessation treatment.
@nl
prefLabel
Impact of bupropion and cognit ...... ke during cessation treatment.
@en
Impact of bupropion and cognit ...... ke during cessation treatment.
@nl
P2093
P2860
P356
P1476
Impact of bupropion and cognit ...... ke during cessation treatment.
@en
P2093
Adam M Leventhal
Ana M Abrantes
Christopher W Kahler
David R Strong
Elizabeth Lloyd-Richardson
Richard A Brown
P2860
P304
P356
10.1093/NTR/NTP111
P577
2009-07-02T00:00:00Z